OrbusNeich Honored in “BOCHK Corporate Low-Carbon Environmental Leadership Awards”

(Hong Kong, August 20, 2025) – OrbusNeich Medical Group Holdings Limited (“OrbusNeich” or the “Group”; stock code: 6929.HK), a multinational medical device company specializing in interventional devices for percutaneous coronary intervention (“PCI”) and percutaneous transluminal angioplasty (“PTA”) procedures, is honored to receive the “BOCHK Corporate Low-Carbon Environmental Leadership Awards”. Recognized as an “EcoPartner” and awarded the ‘Low-Carbon Commitment’ certificate, jointly presented by the Federation of Hong Kong Industries (“FHKI”) and Bank of China (Hong Kong) (“BOCHK”), this accolade underscores the Group’s commitment to eco-friendly operations and sustainable production.

The Group prioritizes sustainable development, reducing resource consumption, protecting the environment, and fostering green supply chains. These initiatives align with our mission to deliver life-changing technologies while upholding ESG principles, improving the long-term quality of life for patients and contributing to a healthier planet.

Mr. David Chien, Chairman, Executive Director and Chief Executive Officer of OrbusNeich, remarked, “This award reflects our steadfast dedication to sustainability.  Across our operations from production to supply chain management, we’ve implemented concrete eco-friendly initiatives. A prime example is our factory energy conservation program, where we’ve replaced high-energy-consumption equipment and optimized operational management to significantly improve energy efficiency. These comprehensive efforts enable us to minimize waste, meet carbon reduction targets, and fulfill our environmental responsibilities. OrbusNeich remains dedicated to advancing ESG principles and will continue investing in sustainability initiatives to realize our low-carbon vision for the future. “

Co-organised by the FHKI and BOCHK since 2015, the awards aims to encourage corporations operating in Hong Kong and the Pan-Pearl River Delta (Pan-PRD) region to implement green measures to fulfil their corporate social responsibility and reduce environmental pollution. This year’s awards attracted over 960 participating companies with 2300 environmental projects.

OrbusNeich was honored with the recognition of ‘EcoPartner’ and ‘Low-Carbon Commitment’ in the ‘BOCHK Corporate Low-Carbon Environmental Leadership Awards’.

－ End －

About OrbusNeich Medical Group Holdings Limited
OrbusNeich is a multinational medical device company specializing in interventional devices for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. Headquartered in Hong Kong, China, our Group sells its products in more than 70 countries and regions worldwide. It is also actively expanding into structural heart disease. With an in-house R&D team boasting over 20 years of product development expertise, our Group has developed world-leading proprietary technologies.